 rais despit recent commun
headwind pt
put beat rais top-line/eps/fcf guidanc
midpoint organ growth beat/rais surpris given recent
telegraph headwind cvg turn bad off-set strength
mitg/rtg emerg market also strong contribut half growth
good result rais pt
portfolio serv ballast beat ritg/mitg/em off-set hit cvg keep top-lin
overal organ growth better expect street
despit headwind cvg call januari slowdown pad recent
meta-analysi katsano et al slowdown lvad heartmat launch
competitor guidelin chang heart transplant lvad
weak declin pressur cvg cc cc last surprisingli
dcb grew mid-teen despit public paclitaxel data appear
coordin effort offer object data refut meta-analysi offset
weak spot better perform mitg ahead forecast
rtg ahead forecast emerg market cc segment
contribut half growth
diabet weak comp breakthrough design solidifi lead ap race
diabet slow cc cc last expect actual
slowdown tough comp due anniversari
bolu patient last year weak expect extend stabil
combin stand-alon cgm sensor sale guardian connect
presum pump gain separ announc breakthrough
design person close loop pcl system design part
fda effort speed approv novel/import technolog pcl devic appear
add autom meal-tim calcul address one main shortcom
autom system lag interstiti glucos eat meal autom
featur new devic move ever closer true artifici pancrea
tweak pt buy result beli recent poor commun
confus around commun earli januari appear
hous actual good shape diabet tough comp soft
spot lvad icd whole notabl growth step
tough comp see steadi acceler new
product kick model outlook margin expans remain
large-cap peer part grow faster also trade ep
versu pt goe prior still discount
ep well balanc underli result valuat support
begin data present pro forma cash
basi includ covidien exclud amort
pleas see analyst certif import disclosur inform inform regard statu non-u analyst
page report
invest thesi base abil achiev mid-
expand product portfolio organ acquisit
achiev ep growth combin leverag
focus cost reduct
tct confer
pipelin regulatori mileston
sustain mid-single-digit top-lin growth next
bp annual op margin expans
volum growth augment new product
entri new market
continu return annual form
dividend buyback
tuck-in acquisit bake base assumpt
pt base adjust ep
sustain mid high-single-digit top-lin growth
volum growth augment new product
entri new market
annual op margin expans
continu return annual form
dividend buyback
large-scal accret bake bull assumpt
pt base adjust ep
overal top-lin growth deceler low-singl digit
next year
volum deceler off-set new product
entri new market
profil erod return diminish
annual
pt base adjust ep
pleas see import disclosur inform page report
financi summari market data
estim valuat
begin data present pro forma cash basi includ covidien exclud amort
pleas see import disclosur inform page report
ep ahead expect despit cvg
tax headwind leverag gain
adjust ep ahead actual despit cvg tax
headwind call earlier year predominantli leverag gain throughout
direct offset tax line share repurchas adj om improv sequenti
sg leverag favor fx gain adj tax
rate better fear despit us reform shift look ahead co
offici shift tax guidanc prior continu expect
offset growth portfolio adj om gain share buyback
co continu improv cash posit guidanc shift
higher prior strengthen balanc sheet debt ratio
suggest co could soon back market current calendar year
pleas see import disclosur inform page report
pleas see import disclosur inform page report
pleas see import disclosur inform page report
